Tempest Therapeutics Inc (NASDAQ:TPST) does about 95.25K shares in volume on a normal day but saw 2238848 shares change hands in the recent trading day. The company now has a market cap of 32.96M USD. Its current market price is $8.95, marking an increase of 8.54% compared to the previous close of $8.25. The 52 week high reached by this stock is $42.12 whilst the lowest price level in 52 weeks is $5.35.
The consensus objective for the share price is $108.50, suggesting that the stock has a potential upside of 91.75% over the period.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Hold the stock.
Scotiabank initiated its price target at $13.
The current price level is 31.78%, 23.96%, and -23.43% away from its SMA20, SMA50, and SMA200 respectively, with the TPST price moving below the 50-day SMA on current market day. Tempest Therapeutics Inc (TPST) stock is up 33.58% over the week and 30.66% over the past month. Its price is -17.50% year-to-date and -79.81% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at -2.65 and -10.31 for whole year.
To reach the target analysts have set, the stock logically needs to grow 91.75 percent from here.
Outstanding shares total 3.52M with insiders holding 0.13% of the shares and institutional holders owning 12.51% of the company’s common stock. The company has a return on investment of -235.95% and return on equity of -282.07%. The beta has a value of -1.95. Price to book ratio is 2.83.
